Clinical Trials · NCT00589472

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
National Cancer Institute (NCI)
Enrollment
19
Start date
Nov 2007
Locations
15 sites, United States
Primary endpoint
Pathologic Complete Response at the Time of Surgery
View Gonadorelin compound reference